Health care pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 health care pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- AED 18.3T
- Countries
- 10
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | AED 36.7B | AED 243.02 | 0.08% up | 117% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | AED 29.9B | AED 431.00 | 1.42% down | 18% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | AED 17.8B | AED 315.26 | 2.21% up | 108% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | AED 30.1B | AED 461.70 | 1.14% down | 51% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | AED 32.2B | AED 1,150.42 | 2.64% up | 86% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | AED 26.2B | AED 188.18 | 0.16% down | 19% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | AED 16.5B | AED 98.94 | 1.64% down | 63% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | AED 21.3B | AED 1,067.00 | 2.74% down | 50% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | AED 34.5B | AED 363.22 | 2.52% down | 332% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | AED 28.5B | AED 169.62 | 1.42% down | 66% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | AED 16.4B | AED 149.92 | 1.33% down | 86% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | AED 56B | AED 287.66 | 0.40% up | 21% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | AED 18B | AED 51.40 | 1.71% up | 395% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | AED 17.9B | AED 103.05 | 0.90% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | AED 22.6B | AED 346.23 | 1.93% up | 34% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | AED 17.3B | AED 180.29 | 2.29% down | 45% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | AED 24.6B | AED 362.91 | 3.21% up | 255% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | AED 18.3B | AED 219.58 | 0.73% down | 21% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | AED 34.2B | AED 1,471.12 | 0.62% up | 27% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | AED 56.7B | AED 882.93 | 2.97% down | 41% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | AED 26.2B | AED 239.64 | 3.75% down | 10% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | AED 22.5B | AED 159.06 | 0.46% up | 13% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | AED 19.2B | AED 454.25 | 0.94% down | 231% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | AED 44.9B | AED 231.63 | 2.67% up | 17% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | AED 14.4B | AED 105.48 | 1.37% down | 168% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | AED 48.7B | AED 97.43 | 0.64% down | 26% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | AED 114B | AED 519.78 | 18.14% up | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | AED 104.6B | AED 144.33 | 1.47% up | 91% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | AED 25.9B | AED 491.80 | 0.07% down | 6% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | AED 11.6B | AED 59.55 | 0.22% down | 41% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | AED 27.5B | AED 349.52 | 0.13% up | 129% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | AED 31.1B | AED 38.93 | 0.95% up | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | AED 26.8B | AED 306.07 | 0.58% down | 32% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | AED 63.5B | AED 968.50 | 2.45% down | 29% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | AED 88.7B | AED 2,083.54 | 1.74% down | 22% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | AED 123.2B | AED 303.21 | 3.52% down | 26% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | AED 73.4B | AED 547.99 | 0.13% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | AED 23B | AED 565.18 | 1.50% down | 43% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | AED 27.4B | AED 78.63 | 2.15% down | 90% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | AED 83.5B | AED 72.86 | 2.17% down | 99% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | AED 45.5B | AED 54.61 | 0.73% down | 8% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | AED 169.9B | AED 145.60 | 6.12% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | AED 580B | AED 101.75 | 1.27% down | 15% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | AED 439.4B | AED 214.98 | 1.72% down | 30% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | AED 143.7B | AED 249.92 | 0.90% down | 79% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | AED 357.5B | AED 3,456.32 | 0.47% down | 28% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | AED 490.3B | AED 1,933.84 | 1.84% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | AED 116.9B | AED 189.54 | 1.26% up | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | AED 169B | AED 1,479.40 | 0.19% down | 16% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | AED 666.1B | AED 384.59 | 0.23% up | 16% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | AED 1.22T | AED 493.14 | 2.54% down | 45% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | AED 1.83T | AED 1,037.77 | 1.20% down | 25% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | AED 20.7B | AED 30.37 | 2.36% down | 0% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | AED 628.9B | AED 142.70 | 1.46% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | AED 4.44T | AED 4,989.96 | 1.74% down | 33% up | ||
| 56 | GSKGSK · Health Care | 0.81% | AED 353.2B | AED 176.19 | 1.25% down | 5% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | AED 2.37T | AED 982.57 | 1.89% down | 34% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | AED 406.3B | AED 169.20 | 2.23% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | AED 1.05T | AED 555.74 | 2.51% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | AED 999.2B | AED 644.27 | 1.87% down | 1% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | AED 251B | AED 78.56 | 0.56% up | 51% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6726 AED).
Questions and answers
Which health care pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 health care pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many health care pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these health care pharmaceutical companies worth together?
The 61 health care pharmaceutical companies ranked by short interest have a combined market value of AED 18.3T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Health care pharmaceutical companies by short interest”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.